As of my last update in October 2023, specific information about the chemical substance "SNRI-IN-1" with the CAS number "887766-95-2" is not widely available in public databases or literature. Generally, substances with such identifiers may be in the realm of research chemicals or investigational compounds, often related to pharmacological studies. Characteristics of such compounds typically include their molecular structure, solubility, stability, and biological activity, which can vary significantly based on their intended use. If "SNRI-IN-1" is related to serotonin-norepinephrine reuptake inhibition, it may exhibit properties that affect neurotransmitter levels in the brain, potentially influencing mood and anxiety. For precise details, including safety data, synthesis methods, and specific applications, consulting specialized chemical databases or scientific literature would be necessary. Always ensure to handle any chemical substance with appropriate safety measures and regulatory compliance.

SNRI-IN-1

887766-95-2: As of my last update in October 2023, specific information about the chemical substance "SNRI-IN-1" with the CAS number "887766-95-2" is not widely available in public databases or literature. Generally, substances with such identifiers may be in the realm of research chemicals or investigational compounds, often related to pharmacological studies. Characteristics of such compounds typically include their molecular structure, solubility, stability, and biological activity, which can vary significantly based on their intended use. If "SNRI-IN-1" is related to serotonin-norepinephrine reuptake inhibition, it may exhibit properties that affect neurotransmitter levels in the brain, potentially influencing mood and anxiety. For precise details, including safety data, synthesis methods, and specific applications, consulting specialized chemical databases or scientific literature would be necessary. Always ensure to handle any chemical substance with appropriate safety measures and regulatory compliance.

SNRI-IN-1 (Compound 7a) acts as a dual inhibitor of serotonin and noradrenaline monoamine reuptake, with a P-glycoprotein Efflux Ratio of 20 [1].

CAS 887766-95-2

SNRI-IN-1

SNRI-IN-1

Ref: TM-T87412